Digital Health Innovators: Sergey Young on how technology can extend... How can humans extend their life span?
Views & Analysis Innovating in inflammation and immunology For World Inflammatory Bowel Disease day we spoke to Pfizer’s Matt Shaulis, president of international developed markets for inflammation and immunology, to hear how the company hopes to ha
Partner Content Partner Content Exclusive interview with Novartis industry leader, Maxime Ga... Exclusive interview with Novartis industry leader
Partner Content Partner Content Regulatory and Policy Keynote Sessions to be Delivered at th... Regulatory and Policy Keynote Sessions to be Delivered
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.